AstraZeneca · 2 days ago
Associate Director, Senior Patient Safety Scientist - Oncology R&D
Wonder how qualified you are to the job?
BiopharmaBiotechnology
Insider Connection @AstraZeneca
Responsibilities
Aggregating, reviewing, analyzing, and interpreting safety-related data to support safety decision-making.
Collaborating with Global Safety Physician and other PV Scientists to support safety strategy and requirements for assigned drug projects.
Providing strategic safety input to regulatory documents such as regulatory reports and health authority responses.
Handling governance board interactions and communication across various safety and scientific activities.
Working effectively in an advanced matrix structure and prioritizing multiple activities simultaneously.
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
A Bachelor’s in sciences/pharmacy/nursing degree or related field
3+ years of proven experience
Patient Safety and/or Clinical/Drug Development proven experience working in safety &/or scientific activities in at least 3 of the following areas: Clinical drug development, Post-Marketing Surveillance, MAA/BLA submissions, Periodic Safety Reports, Risk Management Plans
Governance board interactions and communication across a range of activities
Good knowledge of PV regulations
Demonstrated ability to handle more than one activity simultaneously, prioritizing well and recognizing key issues
Ability to work effectively in an advanced matrix structure
Proficient in written and verbal English
Preferred
MSc/PhD/PharmD in scientific field
2+ years of relevant experience
Understanding of epidemiology
Benefits
Paid time off
Comprehensive benefits package
Company
AstraZeneca
AstraZeneca is a pharmaceutical company that discovers, develops, manufactures, and markets prescription medicines. It is a sub-organization of Investor AB.
Funding
Current Stage
Public CompanyTotal Funding
$3.75B2023-02-28Post Ipo Debt· $2.25B
2023-02-24Post Ipo Debt· $1.5B
2001-05-04IPO· nse:ASTRAZEN
Recent News
http://www.zdnet.com/
2024-06-05
2024-06-05
2024-06-04
Company data provided by crunchbase